Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.

Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.

<h4>Background</h4>Previous trials have often defined genotype 2 and 3 patients as an "easy to treat" group and guidelines recommend similar management.<h4>Aims</h4>The present study looks for differences between the two genotypes and analyzes predictive factors for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Claus Niederau, Stefan Mauss, Andreas Schober, Albrecht Stoehr, Tim Zimmermann, Michael Waizmann, Gero Moog, Stefan Pape, Bernd Weber, Konrad Isernhagen, Petra Sandow, Bernd Bokemeyer, Ulrich Alshuth, Hermann Steffens, Dietrich Hüppe
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/7d1f2f83d9d84eda81a49ca51c12a914
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares